Found: 21
Select item for more details and to access through your institution.
Are neurofilaments valuable biomarkers for long-term disease prognostication in MS?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Insights into microbiome research 1: How to choose appropriate controls for a microbiome study in MS?
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1278, doi. 10.1177/1352458518788967
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2018
- Publication type:
- Correction Notice
Neurofilaments and 10-year follow-up in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1301, doi. 10.1177/1352458518782005
- By:
- Publication type:
- Article
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1276, doi. 10.1177/1352458518771257
- By:
- Publication type:
- Article
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – Yes.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1272, doi. 10.1177/1352458518770970
- By:
- Publication type:
- Article
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – No.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1274, doi. 10.1177/1352458518761571
- By:
- Publication type:
- Article
Clinical commentary on ‘Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis’.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Response to ‘Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?’ by Schiffmann et al.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Exploring the effect of vitamin D<sub>3</sub> supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1280, doi. 10.1177/1352458517722646
- By:
- Publication type:
- Article
Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1356, doi. 10.1177/1352458517722645
- By:
- Publication type:
- Article
Executive functioning in relapsing-remitting multiple sclerosis patients without cognitive impairment: A task-switching protocol.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1328, doi. 10.1177/1352458517719149
- By:
- Publication type:
- Article
Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1317, doi. 10.1177/1352458517717088
- By:
- Publication type:
- Article
Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1347, doi. 10.1177/1352458517721357
- By:
- Publication type:
- Article
Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1288, doi. 10.1177/1352458517721356
- By:
- Publication type:
- Article
Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1337, doi. 10.1177/1352458517720043
- By:
- Publication type:
- Article
Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO).
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1375, doi. 10.1177/1352458517721354
- By:
- Publication type:
- Article
Multimodal characterization of gray matter alterations in neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1308, doi. 10.1177/1352458517721053
- By:
- Publication type:
- Article
Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 10, p. 1366, doi. 10.1177/1352458517720528
- By:
- Publication type:
- Article